14-05-2025
Genefitletics platform now detects cellular health
Indian biotech company
Genefitletics
have enabled their platform to now identify expression levels of specific
biological signals
that could tell the state of health of the cells.
According to the company, the updated platform uses
next-generation sequencing
and
machine learning
to identify and measure biological signals linked to early-stage, asymptomatic
chronic diseases
, enabling individuals to understand, track, and optimize the health of their cells.
The company states that the updated solution provides a
cellular health
score by measuring inflammation, stress, mitochondrial health, immune system activation, and cellular senescence.
Additional features include assessments of triglyceride homeostasis, irritable bowel disease risk, and a feedback loop to monitor how nutritional interventions affect biological pathways in real time.
Commenting on the development, Sushant Kumar, Founder & CEO of Genefitletics said, 'Our platform- PROTEBA trained by 12 billion molecular data points, 45 million phenotype data, 35000 plus peer reviewed research publications & ever evolving clinical insights from new updated research, can now measure expression of certain pathways causing cellular inflammation, cellular senescence, energy efficiency and cellular stress be it hypoxia induced stress, genotoxic stress, oxidative stress or uncoupled protein response.'
